Programmable Bivalent Peptide-DNA Locks for pH-Based Control of Antibody Activity

Wouter Engelen1,2, Kwankwan Zhu1,2, Nikita Subedi2,3

  • 1Laboratory of Chemical Biology, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven 5600 MB, The Netherlands.

ACS Central Science
|January 29, 2020
PubMed
Summary

Researchers developed pH-switchable peptide-DNA ligands to control antibody activity for diagnostics and therapeutics. This innovation enables precise, tunable antibody targeting and detection of single tumor cells.

Related Concept Videos